Buradasınız

Anasayfa » Content

COMPARATIVE STUDY ON EFFICACY & SAFETY OF INTRAVENOUS IRON SUCROSE VERSUS INTRAMUSCULAR IRON SORBITOL THERAPY IN ANEMIA DURING PREGNANCY

Journal Name:

  • International Journal of Medical Research & Health Sciences

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
Aims and Objectives: To compare the efficacy, safety, and rate of response of intravenous iron sucrose and intramuscular iron Sorbitol therapy for anemia during pregnancy. Material and Methods: 100 antenatal cases of gestational age 16-32 weeks were included in this prospective study. Cases were randomly divided into two groups. Group A, having 50 cases received intravenous iron sucrose, and 50cases in group B received intramuscular iron sorbitol. Response to therapy in both groups was studied and compared. Results: The mean pretherapy hemoglobin in group A was 6.49 g/dl and in group B was 6.48 g/dl. The rise in hemoglobin after 4 weeks of starting therapy was 3.52 g/dl in group A and 2.33 g/dl in group B The difference was Statistically significant (P<0.01) The mean time taken to achieve target hemoglobin (>11 g/dl) was 6.37 weeks in group A and 9.04 weeks in group B. In group A, 8% (four) cases had grade I adverse effects. In group B, 24% (12) cases had grade I adverse effects. The difference was statistically significant (P=0.027). In both the groups no case discontinued the therapy. Conclusion: Intravenous iron sucrose is safe, convenient, more effective, and faster acting therapy than intramuscular iron sorbitol therapy for treating moderate to severe anemia during pregnancy.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon 1_deepanjali_etal.pdf
  • 4
719-723
  • English

REFERENCES

References: 

1. Fernando Arias, Shirish ND. Anemia in
pregnancy. Text book of Obstetrics. 2010,
466-469
2. Allen LH. Pregnancy and iron deficiency:
Unresolved Issues. Nutr Rev. 1997; 55; 91-
101.
3. Bayoumeu F, Subiran-Buisset C, Baka NE.
Iron therapy in iron deficiency anemia in
pregnancy: intravenous route versus oral
route. Am J Obstet Gyneco. 2002; 186; 518-
22.
4. Kanani SJ, Poojara RH. Supplementation
with iron & folic acid enhances growth. Jr
Nutrition 2000; 130:452S-455S
5. Perewusny KG, Huck R, Huck A. Parenteral
iron-sucrose complex. Br. J Nutr. 2002;88;3-
10
6. Hashimi Z, Bashir G, Azzem P. Effectiveness
of intra-venous iron sucrose complex versus
intra-muscular iron sorbitol in iron deficiency
anemia. Ann Pak Inst Med Sci. 2006;2;188-
91.
7. Waili A, Mushtaq A. Comparative Studyefficacy.
Safety and compliance of
intravenous iron sucrose and intramuscular
iron sorbitol in iron deficiency anemia of
pregnancy. J Pak Med Assoc. 2002; 52; 392-
95.
8. Raja KS, Janjua NB, Khokhar N. Intravenous
iron Sucrose complex therapy in iron
deficiency anemia in the pregnant women.
Rawal Med J. 2003; 28; 40-3.
9. Sharma JB, Vibha Fatedar. Iron deficiency
anemia in pregnancy. Obs & Gynae Today.
2006;9(3);147-148.
10. Pollitt E, Soemangri AG, Yunis F, cognitive
effects of Iron deficiency anemia. Lancet
1985; 1:158.
11. Lazoff B, Jimenez E, Walf AW long term
developmental out come of infants with iron
deficiency. New Eng I J Med 1991;
325(10):687-95.
12. Abel R, Raja ratnamJ, Sapatkumar V.
Anemia in pregnancy impact of iron, IEC,
RUSHA Depatt Tamilnadu: CMC Vellore
1999.

Thank you for copying data from http://www.arastirmax.com